APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mammalian Cell Culture Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mammalian Cell Culture Service Market Outlook and Growth Opportunities 2026

Report ID 174483400412 August 2026218 pages

Choose your research edition.

Industry ResearchMammalian Cell Culture Service Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Mammalian Cell Culture Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Mammalian Cell Culture Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mammalian Cell Culture Service Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Mammalian Cell Culture Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Mammalian Cell Culture Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mammalian Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mammalian Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mammalian Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mammalian Cell Culture Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mammalian Cell Culture Service market include ARVYS Proteins, Inc., Xell AG, BioXpedia, Biocompare, Sphere Fluidics, Huakan Bio, ABS Inc, Coriell Institute and BiBo Biopharma Engineering Co., LTD., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Mammalian Cell Culture Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mammalian Cell Culture Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mammalian Cell Culture Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mammalian Cell Culture Service market.

Mammalian Cell Culture Service Segment by Company

ARVYS Proteins, Inc.

Xell AG

BioXpedia

Biocompare

Sphere Fluidics

Huakan Bio

ABS Inc

Coriell Institute

BiBo Biopharma Engineering Co., LTD.

Aurelia Bioscience

Rockland

Penn Genetics

Ningbo Mingzhou Biotechnology Co., Ltd.

Lonza

FUJIFILM Diosynth Biotechnologies

Shanghai Sunway Biotech

Lerner Research Institute

Cell Biologics

Cell Culture Company

Novartis

Nordmark Pharma GmbH

Mammalian Cell Culture Service Segment by Type

Primary Cells

Transformed Cells

Self-renewing Cells

Mammalian Cell Culture Service Segment by Application

Production of Vaccines

Production of Monoclonal Antibodies

Production of Therapeutic Proteins

Others

Mammalian Cell Culture Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mammalian Cell Culture Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mammalian Cell Culture Service key companies, revenue, market share, and recent developments.

3. To split the Mammalian Cell Culture Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mammalian Cell Culture Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mammalian Cell Culture Service significant trends, drivers, influence factors in global and regions.

6. To analyze Mammalian Cell Culture Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mammalian Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mammalian Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mammalian Cell Culture Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mammalian Cell Culture Service industry.

Chapter 3: Detailed analysis of Mammalian Cell Culture Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mammalian Cell Culture Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mammalian Cell Culture Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mammalian Cell Culture Service Industry Trends Table 2. Mammalian Cell Culture Service Industry Drivers Table 3. Mammalian Cell Culture Service Industry Opportunities and Challenges Table 4. Mammalian Cell Culture Service Industry Restraints Table 5. Global Mammalian Cell Culture Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mammalian Cell Culture Service Revenue Share by Company (2021-2026) Table 7. Global Mammalian Cell Culture Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mammalian Cell Culture Service Key Company Manufacturing Base & Headquarters Table 9. Global Mammalian Cell Culture Service Company, Product Type & Application Table 10. Global Mammalian Cell Culture Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mammalian Cell Culture Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Primary Cells Table 15. Significant Companies of Transformed Cells Table 16. Significant Companies of Self-renewing Cells Table 17. Global Mammalian Cell Culture Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Mammalian Cell Culture Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Mammalian Cell Culture Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Mammalian Cell Culture Service Sales Value Share by Type (2021-2026) Table 21. Global Mammalian Cell Culture Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Production of Vaccines Table 23. Significant Companies of Production of Monoclonal Antibodies Table 24. Significant Companies of Production of Therapeutic Proteins Table 25. Significant Companies of Others Table 26. Global Mammalian Cell Culture Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Mammalian Cell Culture Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Mammalian Cell Culture Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Mammalian Cell Culture Service Sales Value Share by Application (2021-2026) Table 30. Global Mammalian Cell Culture Service Sales Value Share by Application (2027-2032) Table 31. Global Mammalian Cell Culture Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Mammalian Cell Culture Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Mammalian Cell Culture Service Sales Value Share by Region (2021-2026) Table 34. Global Mammalian Cell Culture Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Mammalian Cell Culture Service Sales Value Share by Region (2027-2032) Table 36. Global Mammalian Cell Culture Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Mammalian Cell Culture Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Mammalian Cell Culture Service Sales Value Market Share by Country (2021-2026) Table 39. Global Mammalian Cell Culture Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Mammalian Cell Culture Service Sales Value Market Share by Country (2027-2032) Table 41. ARVYS Proteins, Inc. Company Information Table 42. ARVYS Proteins, Inc. Business Overview Table 43. ARVYS Proteins, Inc. Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. ARVYS Proteins, Inc. Mammalian Cell Culture Service Product Portfolio Table 45. ARVYS Proteins, Inc. Recent Development Table 46. Xell AG Company Information Table 47. Xell AG Business Overview Table 48. Xell AG Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Xell AG Mammalian Cell Culture Service Product Portfolio Table 50. Xell AG Recent Development Table 51. BioXpedia Company Information Table 52. BioXpedia Business Overview Table 53. BioXpedia Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. BioXpedia Mammalian Cell Culture Service Product Portfolio Table 55. BioXpedia Recent Development Table 56. Biocompare Company Information Table 57. Biocompare Business Overview Table 58. Biocompare Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Biocompare Mammalian Cell Culture Service Product Portfolio Table 60. Biocompare Recent Development Table 61. Sphere Fluidics Company Information Table 62. Sphere Fluidics Business Overview Table 63. Sphere Fluidics Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Sphere Fluidics Mammalian Cell Culture Service Product Portfolio Table 65. Sphere Fluidics Recent Development Table 66. Huakan Bio Company Information Table 67. Huakan Bio Business Overview Table 68. Huakan Bio Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Huakan Bio Mammalian Cell Culture Service Product Portfolio Table 70. Huakan Bio Recent Development Table 71. ABS Inc Company Information Table 72. ABS Inc Business Overview Table 73. ABS Inc Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. ABS Inc Mammalian Cell Culture Service Product Portfolio Table 75. ABS Inc Recent Development Table 76. Coriell Institute Company Information Table 77. Coriell Institute Business Overview Table 78. Coriell Institute Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Coriell Institute Mammalian Cell Culture Service Product Portfolio Table 80. Coriell Institute Recent Development Table 81. BiBo Biopharma Engineering Co., LTD. Company Information Table 82. BiBo Biopharma Engineering Co., LTD. Business Overview Table 83. BiBo Biopharma Engineering Co., LTD. Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. BiBo Biopharma Engineering Co., LTD. Mammalian Cell Culture Service Product Portfolio Table 85. BiBo Biopharma Engineering Co., LTD. Recent Development Table 86. Aurelia Bioscience Company Information Table 87. Aurelia Bioscience Business Overview Table 88. Aurelia Bioscience Mammalian Cell Culture Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Aurelia Bioscience Mammalian Cell Culture Service Product Portfolio Table 90. Aurelia Bioscience Recent Development Table 91. Rockland Company Information Table 92. Rockland Business Overview Table 93. Rockland Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Rockland Mammalian Cell Culture Service Product Portfolio Table 95. Rockland Recent Development Table 96. Penn Genetics Company Information Table 97. Penn Genetics Business Overview Table 98. Penn Genetics Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Penn Genetics Mammalian Cell Culture Service Product Portfolio Table 100. Penn Genetics Recent Development Table 101. Ningbo Mingzhou Biotechnology Co., Ltd. Company Information Table 102. Ningbo Mingzhou Biotechnology Co., Ltd. Business Overview Table 103. Ningbo Mingzhou Biotechnology Co., Ltd. Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Ningbo Mingzhou Biotechnology Co., Ltd. Mammalian Cell Culture Service Product Portfolio Table 105. Ningbo Mingzhou Biotechnology Co., Ltd. Recent Development Table 106. Lonza Company Information Table 107. Lonza Business Overview Table 108. Lonza Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Lonza Mammalian Cell Culture Service Product Portfolio Table 110. Lonza Recent Development Table 111. FUJIFILM Diosynth Biotechnologies Company Information Table 112. FUJIFILM Diosynth Biotechnologies Business Overview Table 113. FUJIFILM Diosynth Biotechnologies Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. FUJIFILM Diosynth Biotechnologies Mammalian Cell Culture Service Product Portfolio Table 115. FUJIFILM Diosynth Biotechnologies Recent Development Table 116. Shanghai Sunway Biotech Company Information Table 117. Shanghai Sunway Biotech Business Overview Table 118. Shanghai Sunway Biotech Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Shanghai Sunway Biotech Mammalian Cell Culture Service Product Portfolio Table 120. Shanghai Sunway Biotech Recent Development Table 121. Lerner Research Institute Company Information Table 122. Lerner Research Institute Business Overview Table 123. Lerner Research Institute Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Lerner Research Institute Mammalian Cell Culture Service Product Portfolio Table 125. Lerner Research Institute Recent Development Table 126. Cell Biologics Company Information Table 127. Cell Biologics Business Overview Table 128. Cell Biologics Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Cell Biologics Mammalian Cell Culture Service Product Portfolio Table 130. Cell Biologics Recent Development Table 131. Cell Culture Company Company Information Table 132. Cell Culture Company Business Overview Table 133. Cell Culture Company Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Cell Culture Company Mammalian Cell Culture Service Product Portfolio Table 135. Cell Culture Company Recent Development Table 136. Novartis Company Information Table 137. Novartis Business Overview Table 138. Novartis Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Novartis Mammalian Cell Culture Service Product Portfolio Table 140. Novartis Recent Development Table 141. Nordmark Pharma GmbH Company Information Table 142. Nordmark Pharma GmbH Business Overview Table 143. Nordmark Pharma GmbH Mammalian Cell Culture Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Nordmark Pharma GmbH Mammalian Cell Culture Service Product Portfolio Table 145. Nordmark Pharma GmbH Recent Development Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Mammalian Cell Culture Service Product Image Figure 2. Global Mammalian Cell Culture Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mammalian Cell Culture Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Mammalian Cell Culture Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Primary Cells Image Figure 8. Transformed Cells Image Figure 9. Self-renewing Cells Image Figure 10. Global Mammalian Cell Culture Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Mammalian Cell Culture Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Mammalian Cell Culture Service Sales Value Share by Type (2021-2032) Figure 13. Production of Vaccines Image Figure 14. Production of Monoclonal Antibodies Image Figure 15. Production of Therapeutic Proteins Image Figure 16. Others Image Figure 17. Global Mammalian Cell Culture Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Mammalian Cell Culture Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Mammalian Cell Culture Service Sales Value Share by Application (2021-2032) Figure 20. Global Mammalian Cell Culture Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Mammalian Cell Culture Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Mammalian Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Mammalian Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Mammalian Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Mammalian Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Mammalian Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Mammalian Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Mammalian Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Mammalian Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Mammalian Cell Culture Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Mammalian Cell Culture Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Primary Cells
  • Transformed Cells
  • Self-renewing Cells
Applications
  • Production of Vaccines
  • Production of Monoclonal Antibodies
  • Production of Therapeutic Proteins
  • Others
Companies covered
  • ARVYS Proteins, Inc.
  • Xell AG
  • BioXpedia
  • Biocompare
  • Sphere Fluidics
  • Huakan Bio
  • ABS Inc
  • Coriell Institute
  • BiBo Biopharma Engineering Co., LTD.
  • Aurelia Bioscience
  • Rockland
  • Penn Genetics
  • Ningbo Mingzhou Biotechnology Co., Ltd.
  • Lonza
  • FUJIFILM Diosynth Biotechnologies
  • Shanghai Sunway Biotech
  • Lerner Research Institute
  • Cell Biologics
  • Cell Culture Company
  • Novartis
  • Nordmark Pharma GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mammalian Cell Culture Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mammalian Cell Culture Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mammalian Cell Culture Service Market Dynamics
  1. 2.1 Mammalian Cell Culture Service Industry Trends
  2. 2.2 Mammalian Cell Culture Service Industry Drivers
  3. 2.3 Mammalian Cell Culture Service Industry Opportunities and Challenges
  4. 2.4 Mammalian Cell Culture Service Industry Restraints
3 Mammalian Cell Culture Service Market by Company
  1. 3.1 Global Mammalian Cell Culture Service Company Revenue Ranking in 2025
  2. 3.2 Global Mammalian Cell Culture Service Revenue by Company (2021-2026)
  3. 3.3 Global Mammalian Cell Culture Service Company Ranking (2024-2026)
  4. 3.4 Global Mammalian Cell Culture Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Mammalian Cell Culture Service Company Product Type and Application
  6. 3.6 Global Mammalian Cell Culture Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mammalian Cell Culture Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mammalian Cell Culture Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mammalian Cell Culture Service Market by Type
  1. 4.1 Mammalian Cell Culture Service Type Introduction
  2. 4.1.1 Primary Cells
  3. 4.1.2 Transformed Cells
  4. 4.1.3 Self-renewing Cells
  5. 4.2 Global Mammalian Cell Culture Service Sales Value by Type
  6. 4.2.1 Global Mammalian Cell Culture Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mammalian Cell Culture Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Mammalian Cell Culture Service Sales Value Share by Type (2021-2032)
5 Mammalian Cell Culture Service Market by Application
  1. 5.1 Mammalian Cell Culture Service Application Introduction
  2. 5.1.1 Production of Vaccines
  3. 5.1.2 Production of Monoclonal Antibodies
  4. 5.1.3 Production of Therapeutic Proteins
  5. 5.1.4 Others
  6. 5.2 Global Mammalian Cell Culture Service Sales Value by Application
  7. 5.2.1 Global Mammalian Cell Culture Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Mammalian Cell Culture Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Mammalian Cell Culture Service Sales Value Share by Application (2021-2032)
6 Mammalian Cell Culture Service Regional Value Analysis
  1. 6.1 Global Mammalian Cell Culture Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mammalian Cell Culture Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mammalian Cell Culture Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mammalian Cell Culture Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mammalian Cell Culture Service Sales Value (2021-2032)
  7. 6.3.2 North America Mammalian Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mammalian Cell Culture Service Sales Value (2021-2032)
  10. 6.4.2 Europe Mammalian Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mammalian Cell Culture Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mammalian Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mammalian Cell Culture Service Sales Value (2021-2032)
  16. 6.6.2 South America Mammalian Cell Culture Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mammalian Cell Culture Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mammalian Cell Culture Service Sales Value Share by Country, 2025 VS 2032
7 Mammalian Cell Culture Service Country-level Value Analysis
  1. 7.1 Global Mammalian Cell Culture Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mammalian Cell Culture Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mammalian Cell Culture Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mammalian Cell Culture Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mammalian Cell Culture Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mammalian Cell Culture Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mammalian Cell Culture Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ARVYS Proteins, Inc.
  2. 8.1.1 ARVYS Proteins, Inc. Company Information
  3. 8.1.2 ARVYS Proteins, Inc. Business Overview
  4. 8.1.3 ARVYS Proteins, Inc. Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ARVYS Proteins, Inc. Mammalian Cell Culture Service Product Portfolio
  6. 8.1.5 ARVYS Proteins, Inc. Recent Developments
  7. 8.2 Xell AG
  8. 8.2.1 Xell AG Company Information
  9. 8.2.2 Xell AG Business Overview
  10. 8.2.3 Xell AG Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xell AG Mammalian Cell Culture Service Product Portfolio
  12. 8.2.5 Xell AG Recent Developments
  13. 8.3 BioXpedia
  14. 8.3.1 BioXpedia Company Information
  15. 8.3.2 BioXpedia Business Overview
  16. 8.3.3 BioXpedia Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioXpedia Mammalian Cell Culture Service Product Portfolio
  18. 8.3.5 BioXpedia Recent Developments
  19. 8.4 Biocompare
  20. 8.4.1 Biocompare Company Information
  21. 8.4.2 Biocompare Business Overview
  22. 8.4.3 Biocompare Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biocompare Mammalian Cell Culture Service Product Portfolio
  24. 8.4.5 Biocompare Recent Developments
  25. 8.5 Sphere Fluidics
  26. 8.5.1 Sphere Fluidics Company Information
  27. 8.5.2 Sphere Fluidics Business Overview
  28. 8.5.3 Sphere Fluidics Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sphere Fluidics Mammalian Cell Culture Service Product Portfolio
  30. 8.5.5 Sphere Fluidics Recent Developments
  31. 8.6 Huakan Bio
  32. 8.6.1 Huakan Bio Company Information
  33. 8.6.2 Huakan Bio Business Overview
  34. 8.6.3 Huakan Bio Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Huakan Bio Mammalian Cell Culture Service Product Portfolio
  36. 8.6.5 Huakan Bio Recent Developments
  37. 8.7 ABS Inc
  38. 8.7.1 ABS Inc Company Information
  39. 8.7.2 ABS Inc Business Overview
  40. 8.7.3 ABS Inc Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ABS Inc Mammalian Cell Culture Service Product Portfolio
  42. 8.7.5 ABS Inc Recent Developments
  43. 8.8 Coriell Institute
  44. 8.8.1 Coriell Institute Company Information
  45. 8.8.2 Coriell Institute Business Overview
  46. 8.8.3 Coriell Institute Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Coriell Institute Mammalian Cell Culture Service Product Portfolio
  48. 8.8.5 Coriell Institute Recent Developments
  49. 8.9 BiBo Biopharma Engineering Co., LTD.
  50. 8.9.1 BiBo Biopharma Engineering Co., LTD. Company Information
  51. 8.9.2 BiBo Biopharma Engineering Co., LTD. Business Overview
  52. 8.9.3 BiBo Biopharma Engineering Co., LTD. Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BiBo Biopharma Engineering Co., LTD. Mammalian Cell Culture Service Product Portfolio
  54. 8.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments
  55. 8.10 Aurelia Bioscience
  56. 8.10.1 Aurelia Bioscience Company Information
  57. 8.10.2 Aurelia Bioscience Business Overview
  58. 8.10.3 Aurelia Bioscience Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurelia Bioscience Mammalian Cell Culture Service Product Portfolio
  60. 8.10.5 Aurelia Bioscience Recent Developments
  61. 8.11 Rockland
  62. 8.11.1 Rockland Company Information
  63. 8.11.2 Rockland Business Overview
  64. 8.11.3 Rockland Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Rockland Mammalian Cell Culture Service Product Portfolio
  66. 8.11.5 Rockland Recent Developments
  67. 8.12 Penn Genetics
  68. 8.12.1 Penn Genetics Company Information
  69. 8.12.2 Penn Genetics Business Overview
  70. 8.12.3 Penn Genetics Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Penn Genetics Mammalian Cell Culture Service Product Portfolio
  72. 8.12.5 Penn Genetics Recent Developments
  73. 8.13 Ningbo Mingzhou Biotechnology Co., Ltd.
  74. 8.13.1 Ningbo Mingzhou Biotechnology Co., Ltd. Company Information
  75. 8.13.2 Ningbo Mingzhou Biotechnology Co., Ltd. Business Overview
  76. 8.13.3 Ningbo Mingzhou Biotechnology Co., Ltd. Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ningbo Mingzhou Biotechnology Co., Ltd. Mammalian Cell Culture Service Product Portfolio
  78. 8.13.5 Ningbo Mingzhou Biotechnology Co., Ltd. Recent Developments
  79. 8.14 Lonza
  80. 8.14.1 Lonza Company Information
  81. 8.14.2 Lonza Business Overview
  82. 8.14.3 Lonza Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lonza Mammalian Cell Culture Service Product Portfolio
  84. 8.14.5 Lonza Recent Developments
  85. 8.15 FUJIFILM Diosynth Biotechnologies
  86. 8.15.1 FUJIFILM Diosynth Biotechnologies Company Information
  87. 8.15.2 FUJIFILM Diosynth Biotechnologies Business Overview
  88. 8.15.3 FUJIFILM Diosynth Biotechnologies Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 FUJIFILM Diosynth Biotechnologies Mammalian Cell Culture Service Product Portfolio
  90. 8.15.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  91. 8.16 Shanghai Sunway Biotech
  92. 8.16.1 Shanghai Sunway Biotech Company Information
  93. 8.16.2 Shanghai Sunway Biotech Business Overview
  94. 8.16.3 Shanghai Sunway Biotech Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Shanghai Sunway Biotech Mammalian Cell Culture Service Product Portfolio
  96. 8.16.5 Shanghai Sunway Biotech Recent Developments
  97. 8.17 Lerner Research Institute
  98. 8.17.1 Lerner Research Institute Company Information
  99. 8.17.2 Lerner Research Institute Business Overview
  100. 8.17.3 Lerner Research Institute Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lerner Research Institute Mammalian Cell Culture Service Product Portfolio
  102. 8.17.5 Lerner Research Institute Recent Developments
  103. 8.18 Cell Biologics
  104. 8.18.1 Cell Biologics Company Information
  105. 8.18.2 Cell Biologics Business Overview
  106. 8.18.3 Cell Biologics Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cell Biologics Mammalian Cell Culture Service Product Portfolio
  108. 8.18.5 Cell Biologics Recent Developments
  109. 8.19 Cell Culture Company
  110. 8.19.1 Cell Culture Company Company Information
  111. 8.19.2 Cell Culture Company Business Overview
  112. 8.19.3 Cell Culture Company Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cell Culture Company Mammalian Cell Culture Service Product Portfolio
  114. 8.19.5 Cell Culture Company Recent Developments
  115. 8.20 Novartis
  116. 8.20.1 Novartis Company Information
  117. 8.20.2 Novartis Business Overview
  118. 8.20.3 Novartis Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Novartis Mammalian Cell Culture Service Product Portfolio
  120. 8.20.5 Novartis Recent Developments
  121. 8.21 Nordmark Pharma GmbH
  122. 8.21.1 Nordmark Pharma GmbH Company Information
  123. 8.21.2 Nordmark Pharma GmbH Business Overview
  124. 8.21.3 Nordmark Pharma GmbH Mammalian Cell Culture Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Nordmark Pharma GmbH Mammalian Cell Culture Service Product Portfolio
  126. 8.21.5 Nordmark Pharma GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst